OpenAlex
PricingAboutJobs
Log inGet started
Author

Xiaojun Liu

Institutions: Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center
Observed institutions: Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center
ORCID: 0000-0003-4432-6435
Observed ORCID: 0000-0003-4432-6435
OpenAlex ID: A5133889675
Results and Exploratory Biomarker Analyses of a Phase II Study CHANGEABLE: Combination of PD‐1 Inhibitor and Niraparib in GErm‐Line‐mutAted Metastatic Breast Cancer
2026 · Jian Zhang, Yiqun Du, et al. · MedComm · 2
Granisetron transdermal delivery system versus palonosetron in the prevention of long-delayed nausea and vomiting: a phase III randomized trial
2026 · Xiaojun Liu, Yanchun Meng, et al. · The Oncologist · 2
Reduced/No Dexamethasone With Netupitant/Palonosetron and Olanzapine for Chemotherapy‑Induced Nausea/Vomiting in Highly Emetogenic Chemotherapy: Phase III Noninferiority Trial
2026 · Yanchun Meng, Yingying Liu, et al. · Journal of Clinical Oncology · 1
Dexamethasone reduction or omission with NEPA and olanzapine for HEC: A phase III trial.
2026 · Jian Zhang, Yanchun Meng, et al. · Journal of Clinical Oncology
Abstract CT289: Phase Ib study of POLQ inhibitor SYN818 combined with olaparib in advanced solid tumors
2026 · Hongxia Wang, Xiaohua Wu, et al. · Cancer Research
Works count: 5
Citation count: 5
H-index: 2
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security